OA
INSY

OFI Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

OFI Advisors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-36
Closed -$1K – 1740
2014
Q2 		$1K Sell
36
-20
-36% -$323 ﹤0.01% 1707
2014
Q1 		$1K Buy
+56
New +$1.11K ﹤0.01% 1719

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTP
Bloom Tree Partners New York $215M AUM 17.45% 1-Year Est. Return

OFI Advisors's INSY Position: Q3 2014 in Review

OFI Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q3 2014, closing a stake of 36 shares — an estimated $1K sold.

OFI Advisors first reported a position in INSY in Q1 2014 and held it in 2 quarters. The position peaked at $1K in Q2 2014. 111 funds tracked by Wall St. Rank hold INSY as of Q3 2014.

  • OFI Advisors reported no remaining Insys Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • OFI Advisors sold 36 Insys Therapeutics, Inc. shares in Q3 2014, an estimated $1K.
  • OFI Advisors first reported a position in Insys Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • OFI Advisors's Insys Therapeutics, Inc. position peaked at $1K in Q2 2014.
  • 111 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2014.

Based on OFI Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.